These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 32219955)

  • 1. Rapid resolution of guttate psoriasis without recurrence for one year following two doses of guselkumab.
    Abbad-Jaime de Aragón C; Berna-Rico E; Jaén P; Blauvelt A; González-Cantero Á
    Int J Dermatol; 2024 Apr; 63(4):534-535. PubMed ID: 38305493
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety profile of guselkumab in treatment of patients with psoriasis and coexisting hepatitis B or C: A multicenter prospective cohort study.
    Huang YH; Yen JS; Li SH; Chiu HY
    J Am Acad Dermatol; 2024 May; 90(5):1083-1086. PubMed ID: 38307145
    [No Abstract]   [Full Text] [Related]  

  • 3. Cemiplimab-Associated Eruption of Generalized Eruptive Keratoacanthoma of Grzybowski.
    Kang BY; Khanna R; Patel MH; Glembocki DJ; Jeffy BG; Thosani MK; Patel NB
    Cutis; 2024 Jan; 113(1):E8-E10. PubMed ID: 38478940
    [No Abstract]   [Full Text] [Related]  

  • 4. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
    Menter A; Van Voorhees AS; Hsu S
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.
    Yamamoto T
    Clin Pharmacol; 2021; 13():135-143. PubMed ID: 34188558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atopic Dermatitis-like Eruption Induced by Two Different Biologics in a Patient with Psoriatic Arthritis.
    Abe F; Mitsuyama S; Nagao E; Kimura M; Higuchi T
    Acta Derm Venereol; 2019 Dec; 99(13):1291-1292. PubMed ID: 31573661
    [No Abstract]   [Full Text] [Related]  

  • 7. Unusual relapse in a psoriasis patient receiving secukinumab: Linear psoriasis.
    Saylam Kurtipek G; Zekey E; Tuncez Akyurek F; Akyurek M; Unal M
    Dermatol Ther; 2020 May; 33(3):e13346. PubMed ID: 32223050
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical course and background of eight patients who discontinued secukinumab after achieving a score of 0 on the psoriasis area and severity index.
    Yasuda M; Morimoto N; Inoue Y; Ishikawa O; Motegi SI
    J Dermatol; 2021 Aug; 48(8):e380-e381. PubMed ID: 34002889
    [No Abstract]   [Full Text] [Related]  

  • 9. Secukinumab-induced scar sarcoidosis in a patient with plaque psoriasis.
    Hlaca N; Zagar T; Kastelan M; Brajac I; Prpic-Massari L
    Australas J Dermatol; 2022 May; 63(2):e187-e189. PubMed ID: 35139232
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of nevoid psoriasis with Secukinumab in a pediatric patient.
    Neema S; Mannu A; Vasudevan B; Bhatt S; Krishnan L; Kashif AW
    Dermatol Ther; 2022 Jun; 35(6):e15456. PubMed ID: 35302696
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: Extension of the 2PRECISE study.
    Mrowietz U; Bachelez H; Burden AD; Rissler M; Sieder C; Orsenigo R; Jagiello P
    J Am Acad Dermatol; 2021 Feb; 84(2):552-554. PubMed ID: 32565211
    [No Abstract]   [Full Text] [Related]  

  • 12. Secukinumab-induced palmar vesiculopustular eruption in a patient with psoriasis.
    Satoh M; Yamamoto T
    Dermatol Ther; 2020 May; 33(3):e13332. PubMed ID: 32219955
    [No Abstract]   [Full Text] [Related]  

  • 13. Secukinumab-induced vitiligo: A new case report and review of the literature.
    Bouzid S; Hammami-Ghorbel H; Chamli A; Aounti I; Daly W; Kochbati S; Fenniche S; Zaouak A
    Therapie; 2023; 78(6):754-756. PubMed ID: 36566160
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.